101 Independent replication and validation of nanopore-based long read sequencing and methylome classification for rapid brain tumour diagnosis

Clicks: 17
ID: 326782
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #200 of 287 articles by views in journal of neuro-oncology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 287 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Introduction Integrated histopathological-molecular analysis is essential to diagnose and guide precision therapies in brain tumours. Whilst standard of care (SoC) diagnostics takes weeks, long read sequencing (LRS) on Oxford Nanopore Technology (ONT) platform and bioinformatics research tools provide rapid diagnosis within hours/days. We independently replicated ONT-LRS diagnostic assay within the NHS. Methods Patients undergoing brain tumour surgery were prospectively consented for surplus tissue sampling for research. LRS was performed on 54 fresh tissue and 78 fresh frozen tissue specimens. University of Birmingham scientists trained NHS staff to extract tumour DNA for sequencing using ONT PromethION flow cells. Research tools ROBIN, EPINN and MethyLYZR were adopted for real-time and batch methylome array. Results 132 specimens from 112 patients were analysed: mean age was 53(16.8); 70(63%) were male; self-reported ethnicity was White(76.5%), Asian(16.2%), Black(2.7%) or other(4.5%). Integrated SoC confirmed Glioblastoma IDH-wild type(59.5%), Astrocytoma IDH-mutant(27%), Oligodendroglioma IDH-mutant, 1p19q-codeleted(12.6%). Diffuse hemispheric glioma(H3G34-mutant; 0.9%), Anaplastic Pleomorphic Xanthoastrocytoma(0.9%), Subependymal gliant cell astrocytoma(0.9%), Pilocytic astrocytoma(0.9%), Meningioma(0.9%), Metastasis (Melanoma, Oesophageal, Renal, 2.7%). Integrating LRS within the SoC neuropathology workflow demonstrated 100% feasibility with no failures in tissue handling, DNA extraction, or sequencing. Amongst prospectively recruited patients(n = 54), NHS SoC integrated diagnosis was reported a median (IQR) of 23(18,32) days after surgery, whilst ROBIN obtained a methylome-based diagnosis within 1.4 days from surgery. In the total population (n = 132), LRS methylome-based diagnostic concordance was 77.6% for EPINN, 75.2% ROBIN and 56% MethyLYZR. Discordant samples included: tumours outside classifier remit(n = 3) and low tumour purity cases(n = 5). Conclusion This demonstrates good concordance between SoC and DNA LRS results. Building on close working partnership between surgeons, pathologists and scientists, we need access to larger, diverse sample populations to refine classifiers and understand their limitations.
Reference Key
openalex_W7204473690 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Vassili Crispi, Luke Ames, Joanne Stockton, Sana Manan, Nicola Chadderton, Lisa James, Sahar Sanai, Tracy Bright, Rajwinder Rai, Santosh Nagaraju, Ute Pohl, P. Taniere, Andrew Beggs, Colin Watts, Victoria Wykes
Are you one of these authors? Claim your profile
Journal journal of neuro-oncology
Year 2026
DOI
10.1093/neuonc/noag172.033
URL
https://academic.oup.com/neuro-oncology/article-pdf/28/Supplement_1/noag172.033/70805848/noag172.033.pdf
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.